Mass Spectrometry Market by Product(Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software & Services), Sample(LC-MS, GC-MS), Application (Omics, Drug Discovery, Food, Environmental), End User(Pharma, Biotech)-Global Forecasts to 2030
세계의 질량 분석 시장 규모는 2024년 63억 3,000만 달러에서 2030년까지 96억 2,000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR 7.2%의 성장이 예상됩니다.
| 조사 범위 |
| 조사 대상 연도 |
2022-2030년 |
| 기준연도 |
2023년 |
| 예측 기간 |
2024-2030년 |
| 단위 |
달러 |
| 부문 |
제품, 샘플 준비 기술, 용도, 최종 사용자, 지역 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
시장의 성장은 PFAS 및 마이크로플라스틱과 같은 분석물의 환경 샘플 검사에서 질량분석기 이용 증가가 예측되기 때문인 것으로 예상됩니다. 제약산업이 연구개발에 더 많은 예산을 할당하고 의약품의 안전성에 관한 정부규제가 질량분석계 수요를 증가시킵니다. 에너지 탐사 및 기후 연구에 대한 투자 증가는 질량 분석기 수요를 자극합니다. 또한 식품 및 음료 검사에 고감도 정성·정량 검사가 의무화됨으로써 질량 분석 시장 수요가 증가할 것으로 예측됩니다.
"제품별로 기구 부문은 2023년 세계 질량 분석 시장에서 가장 큰 점유율을 차지했습니다."
하이브리드 질량 분석 부문은 질량 분석 시장에서 가장 큰 점유율을 차지합니다. 하이브리드 질량 분석은 신속하고 고해상도 검사 능력을 발휘하여 보다 정확하고 정밀한 결과를 얻을 수 있습니다. 하이브리드 질량 분광계는 이온 소스에서 이온 검출기까지 다양한 유형의 질량 분광계를 두 개 이상 순서대로 배치합니다. 이것은 감도, 정밀도, 분해능, 효율성을 크게 향상시켜 채택이 단일 질량 분석기와 비교하여 상당한 수준으로 진행되고 있습니다. 또한, 하이브리드 질량 분석기에서 수행되는 분석은 대량의 복잡한 데이터가 빠르고 고해상도로 얻어지고 정확하고 우수한 분석을 가능하게 하기 때문에 각 회사는 이러한 데이터 세트를 관리하고 분석하는 소프트웨어를 제공하는 경향이 있습니다.
질량분석기 시장의 성장은 주로 분자량 측정에 의한 미지의 물질 분류, 알려진 화합물의 측정, 분자의 구조와 화학적 성질의 결정 등 다양한 용도에 사용할 수 있는 질량 분석계가 제공하는 처리 절차상의 이점에 의해 촉진되고 있습니다.
"샘플 준비 기법별로는 LC-MS 부문이 예측 기간에 가장 큰 점유율을 차지했습니다."
LC-MS는 다양한 복잡한 샘플로부터 얻은 미지의 화합물의 정량 및 확인을 위해 다양한 부문에서 가장 일반적으로 사용되는 분석 기술 중 하나입니다. LC-MS의 사용은 분석에서 선택성과 특이성을 모두 제공하기 때문에 해마다 확대되고 있습니다. 질량분석의 진보는 이 기술의 감도와 정밀도를 더욱 향상시켜 복잡한 샘플 매트릭스에서 낮은 수준의 분석물의 검출과 확인을 가능하게 했습니다. 액체 크로마토그래피(LC)는 분석 전에 시료에서 화합물을 분리하는 데 널리 사용되는 기술이며 질량 분석과 자주 사용됩니다.
타사 검사 서비스 제공업체와 실험실의 새로운 오염물질 검사를 위한 LC-MS의 새로운 용도의 등장은 지난 3년간 증가했습니다. 이러한 모든 조건은 LC-MS가 질량 분석 시장에서 큰 점유율을 얻는 데 도움이 됩니다.
"용도별로는 오믹스 연구 부문이 예측 기간에 가장 빠른 성장을 기록했습니다."
질량 분석계는 고감도로 선택성이 높기 때문에 일염기 다형이나 쇼트 탠덤 반복의 특성 해석을 실시하는 유전체학 연구에도 응용되고 있습니다. 대사체학는 건강한 사람과 2형 당뇨병 환자에서 추출한 대사산물의 혈청 프로파일에서 특이적인 변화를 구별하는 데 도움이 되므로 질량 분석은 당뇨병 연구에서도 유망한 결과를 보여줍니다. 또한 신생아 스크리닝에도 효과적이며 선천성 대사 이상의 다중화 분석 포트폴리오로 연결되어 있습니다.
오믹스 연구 부문은 예측 기간에 큰 성장이 예상됩니다. 바이오의약품 및 바이오테크놀러지 산업은 연구개발 부문에서 진단 바이오마커 식별용도의 진보를 촉진하고 있어 향후 수년간 이 업계의 대폭적인 성장과 우위성으로 이어질 것입니다.
이 보고서는 세계의 질량 분석 시장에 대한 조사 분석을 통해 주요 촉진요인과 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
- 질량 분석 시장 개요
- 질량 분석 시장 점유율 : 제품별(2024년·2030년)
- 질량 분석 시장 : 주입구 유형별(2024년·2030년)
- 질량 분석 시장 : 최종사용자별(2024년?2030년)
- 질량 분석 시장 :지역별(2023년)
제5장 시장 개요
- 소개
- 시장 역학
- 고객사업에 영향을 주는 동향/혼란
- 가격 분석
- 평균 판매 가격 동향 : 주요 기업별
- 평균 판매 가격의 동향 :지역별
- 밸류체인 분석
- 연구개발
- 원재료 조달, 제품 개발
- 마케팅, 판매, 유통
- 애프터 서비스
- 공급망 분석
- 생태계 분석
- 투자와 자금조달 시나리오
- 기술 분석
- 특허 분석
- 무역 분석
- HS코드 9027의 수입 시나리오
- HS코드 9027의 수출 시나리오
- 주요 컨퍼런스 및 이벤트(2025-2026년)
- 사례 연구 분석
- 규제 상황
- Porter's Five Forces 분석
- 주요 이해관계자와 구매 기준
- 미충족 요구
- 질량 분석 시장에 대한 AI/생성형 AI의 영향
- 소개
- 질량 분석 시장 잠재력
- AI의 이용 사례
- AI를 도입하고 있는 주요 기업
- 질량 분석 생태계에서 AI/생성형 AI의 미래
제6장 질량 분석 시장 : 주입구 유형별
- 소개
- LC-MS
- GC-MS
- ICP-MS
- 기타 주입구 유형
제7장 질량 분석 시장 : 제품별
- 소개
- 기구
- 하이브리드 질량 분석기
- 싱글 질량 분석기
- 기타 질량 분석기
- 소프트웨어 및 서비스
제8장 질량 분석 시장 : 용도별
- 소개
- 오믹스 연구
- 창약
- 환경시험
- 식품검사
- 의약품/바이오의약품 제조
- 임상 진단
- 응용과학
- 기타 용도
제9장 질량 분석 시장 : 최종 사용자별
- 소개
- 제약기업
- 바이오테크놀러지 기업
- 연구실·학술 기관
- 환경 시험소
- 식품 및 음료 산업
- 법의학 연구소
- 석유화학산업
- 기타 최종 사용자
제10장 질량 분석 시장 :지역별
- 소개
- 북미
- 유럽
- 유럽의 거시 경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 아시아태평양의 거시 경제 전망
- 일본
- 중국
- 인도
- 한국
- 호주
- 동남아시아
- 기타 아시아태평양
- 라틴아메리카
- 라틴아메리카의 거시 경제 전망
- 브라질
- 멕시코
- 기타 라틴아메리카
- 중동 및 아프리카
- 중동 및 아프리카의 거시 경제 전망
- GCC 국가
- 기타 중동?아프리카
제11장 경쟁 구도
- 소개
- 주요 진입기업의 전략/강점
- 수익 분석(2019-2023년)
- 시장 점유율 분석(2023년)
- 시장 랭킹 분석(2023년)
- 기업 평가 및 재무 지표
- 브랜드/제품 비교
- 기업의 평가 매트릭스: 주요 기업(2023년)
- 기업의 평가 매트릭스: 스타트업/중소기업(2023년)
- 경쟁 시나리오
제12장 기업 프로파일
- 주요 기업
- AGILENT TECHNOLOGIES, INC.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORPORATION
- DANAHER
- BRUKER
- SHIMADZU CORPORATION
- MKS INSTRUMENTS
- PERKINELMER
- JEOL LTD.
- HITACHI HIGH-TECH CORPORATION
- TELEDYNE TECHNOLOGIES INCORPORATED
- AMETEK.INC.
- JASCO CORPORATION
- F. HOFFMANN-LA ROCHE LTD
- 기타 기업
- ANALYTIK JENA GMBH CO. KG
- HIDEN ANALYTICAL
- LECO CORPORATION
- RIGAKU HOLDINGS CORPORATION
- YOUNGIN CHROMASS
- SCION INSTRUMENTS
- KORE TECHNOLOGY
- PROCESS INSIGHTS, INC.
- MASSTECH
- ADVION, INC.
- SPACETEK TECHNOLOGY AG
- ELEMENTAR ANALYSENSYSTEME GMBH
- SKYRAY INSTRUMENTS USA, INC.
- MICROSAIC
- PFEIFFER VACUUM FAB SOLUTIONS
제13장 부록
JHS
The global mass spectrometry market is estimated to reach USD 9.62 billion by 2030 from USD 6.33 billion in 2024, at a CAGR of 7.2% during the forecast period.
| Scope of the Report |
|---|
| Years Considered for the Study | 2022-2030 |
| Base Year | 2023 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD) |
| Segments | Product, Sample Preparation Technique, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
The market's growth can be attributed to mass spectrometers' applications in environmental sample testing of analytes like PFAS and microplastics in environmental testing which are expected to increase. The pharmaceutical industry's allocation of larger budgets for research and development and government regulation on drug safety will increase demand for mass spectrometers. Increasing investments in energy exploration and climate studies will stimulate demand for mass spectrometers. Also, the sensitive qualitative and quantitative mandates for food and beverage testing are expected to increase the demand in the mass spectrometry market.
"In terms of product, the instruments segment accounted the largest share in the global mass spectrometry market for the year 2023"
Based on the product, the mass spectrometry is segmented into instruments and software & services. The hybrid mass spectrometry segment accounts for the largest share of the mass spectrometry market. Hybrid mass spectrometers exhibit, rapid and high-resolution testing abilities with more accurate and precise results. Hybrid mass spectrometers incorporate at least two component mass analyzers of different types arranged in sequence from the ion source to the ion detector. This greatly increases their sensitivity, accuracy, resolution, and efficiency, which drives their adoption on a significant level when compared to single mass analyzers. Moreover, analyses performed with hybrid mass spectrometers yield large volumes of complex data at high speed and resolution and result in accurate and better analysis, companies tend to provide software to manage and analyze such data sets.
The growth of the mass spectrometry instruments market will primarily be driven by the procedural benefits offered by mass spectrometers as they can be used for different applications, such as classifying unknown substances by molecular weight measurement, measuring known compounds, and determining the structure and chemical properties of molecules.
"In terms of sample preparation technique, the LC-MS segment accounted for the largest share during the forecast period"
LC-MS is one of the most commonly used analytical techniques in various sectors for the quantitation and identification of unknowns from a variety of complex samples. The use of LC-MS has expanded over the years as it offers both selectivity and specificity in analysis. With advances in mass spectrometry, the sensitivity and accuracy of this technique have further increased, allowing for the detection and identification of low-level analytes in complex sample matrices. Liquid chromatography (LC) is a technique widely used to separate compounds from a sample before analysis and is frequently coupled to mass spectrometry.
The advent of new applications of LC-MS for testing emerging contaminants from third-party testing service providers and labs has increased in the last three years. All these conditions have helped LC-MS to acquire a major share in the mass spectrometry market.
"In terms of applications, the OMICS research segment registered the fastest growth during the forecast period"
Due to the high sensitivity and selection of mass spectrometry, it has also found applications in genomics research to characterize single nucleotide polymorphisms and short tandem repeats. In metabolomics, mass spectrometry has also shown promising results in diabetes studies, as it helps in distinguishing specific changes in the serum profile of metabolites extracted from healthy people and those with type 2 diabetes mellitus. It is also effective in newborn screening, leading to a portfolio of multiplexing assays for congenital metabolic errors.
The OMICS research segment is expected to witness significant growth during the forecast period. The biopharmaceutical and biotechnology industries have facilitated the advancement of diagnostics & biomarker identification applications in the R&D sector, leading to its significant growth and dominance in the industry in the upcoming years.
"In terms of end users, the pharmaceutical companies acquired the largest share of the global mass spectrometry market."
Several regulations for pharmaceutical manufacturing sites have been implemented that confines the metal residues and endotoxins in pharmaceutical products to certain limits, this is quantified on parameters for active pharmaceutical ingredients (API) in production volume. These constrictions have prompted pharmaceutical companies to procure and utilize mass spectrometers in their QC departments. Also, the anticipated revenue growth of this segment during the forecast period is attributed to the rapid expansion of the pharmaceutical industry worldwide and the technological advancements in the pharmaceutical sectors.
All these factors have favored the adoption mass spectrometry technique more to deliver quality end products.
"The market in the North America region is expected to hold significant market share for mass spectrometry in 2023."
The mass spectrometry market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for mass spectrometry in 2023. The growth of the mass spectrometry market in this region can be attributed to the increasing investments in pharmaceutical R&D and government funding for R&D activities.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 -35%, Tier 2- 45%, and Tier 3- 20%
- By Designation: C-level- 35%, Directors-25%, and Others-40%
- By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%
The key players profiled in the mass spectrometry market are Agilent Technologies, Inc. (US) Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Waters Corporation (US), Bruker Corporation (US), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), Jeol Ltd (Japan), Jasco (Japan) Teledyne Technologies Incorporated (US), MKS Instruments (US), Ametek, Inc (US), Hitachi High-Tech Corporation (Japan)
Research Coverage
The research report examines the mass spectrometry market by product, sample preparation technique, application, end-users, and geography. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions along with micro-market analysis.
Rationale to Buy the Report
The research report will help smaller and newer businesses as well as established ones understand the state of the market, which will help them increase their market share. Businesses that purchase the study may choose to employ one or more of the tactics listed below to increase their market presence.
This report provides insightful data on the following pointers:
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market.
- Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market.
- Market Development: Insightful data on profitable developing areas.
- Market Diversification: Details about recent developments and advancements in the mass spectrometry market.
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1.1 RESEARCH DATA
- 2.1.2 SECONDARY DATA
- 2.1.2.1 Indicative list of secondary sources
- 2.1.2.2 Key data from secondary sources
- 2.1.3 PRIMARY DATA
- 2.1.3.1 Primary sources
- 2.1.3.2 Key data from primary sources
- 2.1.3.3 Key industry insights
- 2.1.3.4 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
- 2.2.2 END USER-BASED MAPPING MARKET ESTIMATION
- 2.3 GROWTH FORECASTING MODEL
- 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 MASS SPECTROSCOPY MARKET OVERVIEW
- 4.2 MASS SPECTROSCOPY MARKET SHARE, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
- 4.3 MASS SPECTROSCOPY MARKET, BY INLET TYPE, 2024 VS. 2030 (USD MILLION)
- 4.4 MASS SPECTROSCOPY MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
- 4.5 MASS SPECTROSCOPY MARKET, BY REGION, 2023
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing regulatory emphasis and privatization of environmental testing services
- 5.2.1.2 Growing application of mass spectrometry in clinical and forensic settings
- 5.2.1.3 Rising focus on drug safety
- 5.2.1.4 Increasing investments in pharmaceutical research & development
- 5.2.2 RESTRAINTS
- 5.2.2.1 Capital-intensive investments for high-end equipment
- 5.2.2.2 Time-consuming sample preparation steps
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Development of novel mass sensors and nanopore ion sources
- 5.2.3.2 Growth opportunities in emerging economies
- 5.2.4 CHALLENGES
- 5.2.4.1 Inadequate infrastructure and shortage of skilled professionals
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
- 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
- 5.5 VALUE CHAIN ANALYSIS
- 5.5.1 R&D
- 5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT DEVELOPMENT
- 5.5.3 MARKETING, SALES, AND DISTRIBUTION
- 5.5.4 AFTERMARKET SERVICES
- 5.6 SUPPLY CHAIN ANALYSIS
- 5.6.1 PROMINENT COMPANIES
- 5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
- 5.6.3 END USERS
- 5.6.4 SALES AND DISTRIBUTION
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 INVESTMENT AND FUNDING SCENARIO
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
- 5.9.1.1 Quadrupole mass analyzers
- 5.9.1.2 Time-of-flight mass analyzers
- 5.9.1.3 Ion trap mass analyzers
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.9.2.1 LC-MS
- 5.9.2.2 GC-MS
- 5.9.3 ADJACENT TECHNOLOGIES
- 5.9.3.1 Mass spectrometry imaging
- 5.10 PATENT ANALYSIS
- 5.11 TRADE ANALYSIS
- 5.11.1 IMPORT SCENARIO FOR HS CODE 9027
- 5.11.2 EXPORT SCENARIO FOR HS CODE 9027
- 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
- 5.13 CASE STUDY ANALYSIS
- 5.13.1 USE OF MASS SPECTROMETRY INSTRUMENTS FOR CLINICAL DIAGNOSTICS
- 5.14 REGULATORY LANDSCAPE
- 5.14.1 REGULATORY ANALYSIS
- 5.14.1.1 North America
- 5.14.1.2 Europe
- 5.14.1.3 Asia Pacific
- 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.15 PORTER'S FIVE FORCE ANALYSIS
- 5.15.1 BARGAINING POWER OF SUPPLIERS
- 5.15.2 BARGAINING POWER OF BUYERS
- 5.15.3 THREAT OF NEW ENTRANTS
- 5.15.4 THREAT OF SUBSTITUTES
- 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.16.2 KEY BUYING CRITERIA
- 5.17 UNMET NEEDS
- 5.18 IMPACT OF AI/GEN AI ON MASS SPECTROMETRY MARKET
- 5.18.1 INTRODUCTION
- 5.18.2 MARKET POTENTIAL OF MASS SPECTROMETRY
- 5.18.3 AI USE CASES
- 5.18.4 KEY COMPANIES IMPLEMENTING AI
- 5.18.5 FUTURE OF AI/GEN AI IN MASS SPECTROMETRY ECOSYSTEM
6 MASS SPECTROMETRY MARKET, BY INLET TYPE
- 6.1 INTRODUCTION
- 6.2 LC-MS
- 6.2.1 REGULATORY SHIFT TO BOOST MARKET
- 6.3 GC-MS
- 6.3.1 INCREASING FOCUS ON ANALYZING ENVIRONMENTAL CONTAMINANTS TO SUSTAIN GROWTH
- 6.4 ICP-MS
- 6.4.1 NEED FOR SIMPLE SAMPLE PREPARATION AND HIGH THROUGHPUT TO BOLSTER GROWTH
- 6.5 OTHER INLET TYPES
7 MASS SPECTROMETRY MARKET, BY PRODUCT
- 7.1 INTRODUCTION
- 7.2 INSTRUMENTS
- 7.2.1 HYBRID MASS SPECTROMETRY INSTRUMENTS
- 7.2.1.1 Triple quadrupole MS
- 7.2.1.1.1 Rising use of advanced analytical instruments to bolster growth
- 7.2.1.2 Quadrupole-time of flight MS
- 7.2.1.2.1 Increasing use of Q-TOF mass spectrometry for metabolomics research and food authenticity testing to facilitate growth
- 7.2.1.3 Fourier transform MS
- 7.2.1.3.1 Need for high resolution and mass measurement accuracy to increase growth
- 7.2.2 SINGLE MASS SPECTROMETRY INSTRUMENTS
- 7.2.2.1 Quadrupole MS
- 7.2.2.1.1 Growing applications of quadrupole mass spectrometers in biotechnology and pharmaceutical industries to drive market
- 7.2.2.2 Time-of-flight MS
- 7.2.2.2.1 Increasing focus on biological analysis applications to expedite growth
- 7.2.2.3 Ion trap MS
- 7.2.2.3.1 Need for enhanced capabilities in research areas to contribute to growth
- 7.2.3 OTHER MASS SPECTROMETRY INSTRUMENTS
- 7.3 SOFTWARE & SERVICES
- 7.3.1 ONGOING AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO AUGMENT GROWTH
8 MASS SPECTROMETRY MARKET, BY APPLICATION
- 8.1 INTRODUCTION
- 8.2 OMICS RESEARCH
- 8.2.1 GROWING ADVANCEMENTS IN BIOLOGICAL RESEARCH IN PROTEOMICS AND GENOMICS TO PROPEL MARKET
- 8.3 DRUG DISCOVERY
- 8.3.1 NEED FOR HIGHER EFFICACY AND PRODUCT QUALITY TO ENCOURAGE GROWTH
- 8.4 ENVIRONMENTAL TESTING
- 8.4.1 GROWING WATER POLLUTION AND ENFORCEMENT OF ENVIRONMENTAL PROTECTION TO FUEL MARKET
- 8.5 FOOD TESTING
- 8.5.1 INCREASING IMPORTANCE OF SAFETY STANDARDS TO AMPLIFY GROWTH
- 8.6 PHARMA/BIOPHARMA MANUFACTURING
- 8.6.1 RISING USE OF MASS SPECTROMETRY IN PESTICIDE RESIDUE ANALYSIS, PROTEIN IDENTIFICATION, AND CARBON DATING TO AID GROWTH
- 8.7 CLINICAL DIAGNOSTICS
- 8.7.1 GROWING USE OF MASS SPECTROMETRY IN DRUG MONITORING, TOXICOLOGY, AND ENDOCRINOLOGY TO DRIVE MARKET
- 8.8 APPLIED SCIENCES
- 8.8.1 NEED FOR QUALITY CONTROL IN SEMICONDUCTOR INDUSTRY TO SUPPORT GROWTH
- 8.9 OTHER APPLICATIONS
9 MASS SPECTROMETRY MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 PHARMACEUTICAL COMPANIES
- 9.2.1 BOOMING CLINICAL TRIALS AND DRUG DISCOVERY TO STIMULATE GROWTH
- 9.3 BIOTECHNOLOGY COMPANIES
- 9.3.1 GROWING ADOPTION OF MASS SPECTROMETRY IN AGRICULTURE, PROTEOMICS, GENOMICS, AND FOOD TECHNOLOGY TO DRIVE MARKET
- 9.4 RESEARCH LABS & ACADEMIC INSTITUTES
- 9.4.1 INCREASING MASS SPECTROMETRY APPLICATIONS IN METABOLIC FINGERPRINTING ANALYSIS AND BIOMARKER DISCOVERY TO AID GROWTH
- 9.5 ENVIRONMENTAL TESTING LABS
- 9.5.1 INCREASING SOIL AND POLLUTION MONITORING TO SPEED UP GROWTH
- 9.6 FOOD & BEVERAGE INDUSTRY
- 9.6.1 GROWING DEMAND FOR HIGH-QUALITY, SAFE, AND NUTRITIOUS PRODUCTS TO FUEL MARKET
- 9.7 FORENSIC LABS
- 9.7.1 RISING TECHNOLOGICAL ADVANCEMENTS IN FORENSIC SCIENCE TO SUSTAIN GROWTH
- 9.8 PETROCHEMICAL INDUSTRY
- 9.8.1 GROWING OIL DEMAND TO DRIVE MARKET
- 9.9 OTHER END USERS
10 MASS SPECTROMETRY MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
- 10.2.2.1 Increasing availability of funding research to augment growth
- 10.2.3 CANADA
- 10.2.3.1 Growing focus on clean energy technology to propel market
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
- 10.3.2.1 Increasing adoption of advanced mass spectrometry in healthcare to expedite growth
- 10.3.3 UK
- 10.3.3.1 Rising focus on testing food products to sustain growth
- 10.3.4 FRANCE
- 10.3.4.1 Increasing emphasis on molecular-scale data storage to favor growth
- 10.3.5 ITALY
- 10.3.5.1 Growing utilization of mass spectrometry among pharmaceutical and biotechnology end-use industries to drive market
- 10.3.6 SPAIN
- 10.3.6.1 Growing pharmaceutical exports to boost market
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 JAPAN
- 10.4.2.1 Progressive manufacturing landscape to augment growth
- 10.4.3 CHINA
- 10.4.3.1 Increasing investments in scientific R&D to advance growth
- 10.4.4 INDIA
- 10.4.4.1 Increasing focus on environmental technology market to boost market
- 10.4.5 SOUTH KOREA
- 10.4.5.1 Rising focus on biotechnology to stimulate growth
- 10.4.6 AUSTRALIA
- 10.4.6.1 Increasing focus on early disease diagnosis and development of RNA therapies to aid growth
- 10.4.7 SOUTHEAST ASIA
- 10.4.7.1 Growing focus on developing and commercializing innovative drugs to fuel market
- 10.4.8 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
- 10.5.2.1 Booming biomanufacturing and life sciences industries to encourage growth
- 10.5.3 MEXICO
- 10.5.3.1 Expanding local manufacturing capabilities to accelerate growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Favorable government initiatives to contribute to growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MASS SPECTROMETRY MARKET
- 11.3 REVENUE ANALYSIS, 2019-2023
- 11.4 MARKET SHARE ANALYSIS, 2023
- 11.5 MARKET RANKING ANALYSIS, 2023
- 11.6 COMPANY VALUATION AND FINANCIAL METRICS
- 11.7 BRAND/PRODUCT COMPARISON
- 11.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.8.1 STARS
- 11.8.2 EMERGING LEADERS
- 11.8.3 PERVASIVE PLAYERS
- 11.8.4 PARTICIPANTS
- 11.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 11.8.5.1 Company footprint
- 11.8.5.2 Region footprint
- 11.8.5.3 Product footprint
- 11.8.5.4 Application footprint
- 11.8.5.5 End-user footprint
- 11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.9.1 PROGRESSIVE COMPANIES
- 11.9.2 RESPONSIVE COMPANIES
- 11.9.3 DYNAMIC COMPANIES
- 11.9.4 STARTING BLOCKS
- 11.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
- 11.9.5.1 Detailed list of key startups/SMEs
- 11.9.5.2 Competitive benchmarking of key startups/SMEs
- 11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES AND APPROVALS
- 11.10.2 DEALS
- 11.10.3 EXPANSIONS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 AGILENT TECHNOLOGIES, INC.
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Product launches and approvals
- 12.1.1.3.2 Deals
- 12.1.1.3.3 Expansions
- 12.1.1.4 MnM view
- 12.1.1.4.1 Right to win
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 THERMO FISHER SCIENTIFIC INC.
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product launches and approvals
- 12.1.2.3.2 Deals
- 12.1.2.3.3 Expansions
- 12.1.2.4 MnM view
- 12.1.2.4.1 Right to win
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses and competitive threats
- 12.1.3 WATERS CORPORATION
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 Recent developments
- 12.1.3.3.1 Product launches and approvals
- 12.1.3.3.2 Deals
- 12.1.3.3.3 Expansions
- 12.1.3.4 MnM view
- 12.1.3.4.1 Right to win
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses and competitive threats
- 12.1.4 DANAHER
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 Recent developments
- 12.1.4.3.1 Product launches and approvals
- 12.1.4.3.2 Deals
- 12.1.4.3.3 Expansions
- 12.1.4.4 MnM view
- 12.1.4.4.1 Right to win
- 12.1.4.4.2 Strategic choices
- 12.1.4.4.3 Weaknesses and competitive threats
- 12.1.5 BRUKER
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 Recent developments
- 12.1.5.3.1 Product launches and approvals
- 12.1.5.3.2 Deals
- 12.1.5.3.3 Expansions
- 12.1.5.4 MnM view
- 12.1.5.4.1 Right to win
- 12.1.5.4.2 Strategic choices
- 12.1.5.4.3 Weaknesses and competitive threats
- 12.1.6 SHIMADZU CORPORATION
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Product launches and approvals
- 12.1.6.3.2 Deals
- 12.1.6.3.3 Expansions
- 12.1.7 MKS INSTRUMENTS
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.8 PERKINELMER
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.8.3 Recent developments
- 12.1.8.3.1 Product launches and approvals
- 12.1.8.3.2 Deals
- 12.1.9 JEOL LTD.
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.10 HITACHI HIGH-TECH CORPORATION
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.10.3 Recent developments
- 12.1.10.3.1 Other developments
- 12.1.11 TELEDYNE TECHNOLOGIES INCORPORATED
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.11.3 Recent developments
- 12.1.12 AMETEK.INC.
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.13 JASCO CORPORATION
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 F. HOFFMANN-LA ROCHE LTD
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.14.3 Recent developments
- 12.1.14.3.1 Product launches and approvals
- 12.2 OTHER PLAYERS
- 12.2.1 ANALYTIK JENA GMBH+CO. KG
- 12.2.2 HIDEN ANALYTICAL
- 12.2.3 LECO CORPORATION
- 12.2.4 RIGAKU HOLDINGS CORPORATION
- 12.2.5 YOUNGIN CHROMASS
- 12.2.6 SCION INSTRUMENTS
- 12.2.7 KORE TECHNOLOGY
- 12.2.8 PROCESS INSIGHTS, INC.
- 12.2.9 MASSTECH
- 12.2.10 ADVION, INC.
- 12.2.11 SPACETEK TECHNOLOGY AG
- 12.2.12 ELEMENTAR ANALYSENSYSTEME GMBH
- 12.2.13 SKYRAY INSTRUMENTS USA, INC.
- 12.2.14 MICROSAIC
- 12.2.15 PFEIFFER VACUUM+FAB SOLUTIONS
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
